H
HIER Institute
Cardiovascular Oncology Research
Publications & Funding

A decade of high-impact discovery.

The platform is engineered to sustain dozens of manuscripts across cardiovascular oncology imaging, artificial intelligence, radiomics, dosimetry, implementation science, and outcomes research — supported by a rigorously pursued external funding strategy.

Publication Pipeline

Illustrative manuscripts.

01
Automated coronary artery calcium quantification on radiation planning CT.
02
Radiation dose to individual cardiac substructures and subsequent cardiovascular events.
03
AI-enabled opportunistic cardiovascular screening in oncology.
04
Radiomic signatures of radiation-associated cardiotoxicity.
05
Body composition biomarkers and treatment tolerance.
06
Sarcopenia as a predictor of cardiovascular and oncologic outcomes.
07
Valvular calcification detected on planning CT as a marker of long-term cardiovascular risk.
08
Thoracic aortic calcification and survival after thoracic radiotherapy.
09
Epicardial adipose tissue volume and immune checkpoint inhibitor–associated cardiotoxicity.
10
Machine learning models integrating imaging, dosimetry, and clinical data for prediction of major adverse cardiovascular events.
Funding Strategy

Major grant opportunities.

The initiative is designed from inception to align with the largest cardiovascular, oncologic, and imaging science funding mechanisms.

National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
American Heart Association (AHA)
American Society for Radiation Oncology (ASTRO)
American Society of Clinical Oncology (ASCO)
Patient-Centered Outcomes Research Institute (PCORI)
Department of Defense CDMRP
Intellectual Property & Translation

Beyond publication — deployment.

The pipeline extends past manuscripts into intellectual property, industry partnerships, decision-support tools, and clinically actionable innovations that can be embedded directly into radiation oncology workflows.

Intellectual Property

Algorithms, workflows, and decision-support tools protected and licensed through HIER Institute.

Industry Partnerships

Collaborations with imaging vendors, treatment planning software, and cardiovascular device companies.

Clinical Translation

Embedded pragmatic trials and workflow integrations that place discoveries into daily cancer care.